Drug Pipe lines

L&J-AD

Alzheimer’s Disease, Protein therapeutics targeting Amyloid-beta and p-Tau

  • R&D
  • Preclinical
  • Phase I
  • Phase II
  • Phase II
  • NDA

L&J-DM

Diabetes Mellitus, Protein therapeutics

  • R&D
  • Preclinical
  • Phase I
  • Phase II
  • Phase II
  • NDA

L&J-AP

Protein therapeutics targeting Alopecia

  • R&D
  • Preclinical
  • Phase I
  • Phase II
  • Phase II
  • NDA

L&J-PA

Protein/Peptide therapeutics targeting chronic pain

  • R&D
  • Preclinical
  • Phase I
  • Phase II
  • Phase II
  • NDA

L&J-PD

Parkinson’s Disease, Protein

  • R&D
  • Preclinical
  • Phase I
  • Phase II
  • Phase II
  • NDA

L&J-HZ

Herpes Zoster, Chemical

  • R&D
  • Preclinical
  • Phase I
  • Phase II
  • Phase II
  • NDA

L&J-EB

Enbrel Biosimilar

  • R&D
  • Preclinical
  • Phase I
  • Phase II
  • Phase II
  • NDA

L&J-HR

Herceptin Biosimilar

  • R&D
  • Preclinical
  • Phase I
  • Phase II
  • Phase II
  • NDA

Bio Device

L&J-NF

Next generation Fiber bioreactor

  • R&D
  • Proof of concept
  • Beta test